Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the death
of dopaminergic neurons in the substantia nigra and appearance of protein aggregates …

The progressive improvement of the living conditions and medical care of the population in
industrialized countries has led to improvement in healthcare interventions, including …

Cognitive impairment (CI) is common in α-synucleinopathies, ie, Parkinson's disease, Lewy
bodies dementia, and multiple system atrophy. We summarize data from systematic …

The evidence reviewed here, despite preliminary, is very encouraging and suggests strong
rationale for combining pharmacological and non-pharmacological interventions with …

Background Cognitive deficits are common nonmotor symptoms in Parkinson's disease
(PD). Non-Invasive Brain Stimulation (NIBS) could be a potential aid to prevent or delay …

Parkinson's disease is a neurological disorder that affects both motor and non-motor
functions, including depression, anxiety, and cognitive decline. Currently, it remains a …

Parkinson's Disease (PD) is a progressive neurodegenerative disorder characterized by a
range of motor and non-motor symptoms (NMSs) that significantly impact patients' quality of …

The symptomatic treatment of Parkinson's disease (PD) has been dominated by the use of
dopaminergic medication, but significant unmet need remains, much of which is related to …

ABSTRACT Introduction Cognitive impairment in Parkinson's disease (PD) substantially
affects patient outcomes, function, and quality of life. PD-related cognitive dysfunction is …

Parkinson's Disease (PD) is a multifaceted neurodegenerative disorder characterized, in
addition to the well-recognized motor disturbances, by a complex interplay between …